IL6 and autoimmune disease: To this point, studies evaluating the role of JAKinibs and JAK/STAT pathways in autoimmune diseases mainly investigated their anti-inflammatory effects, which are partly the results of their ability to modulate the activation state of pro-inflammatory macrophages by down-regulating IFNβ signature and IL-6 expression.